Malignant neoplasm of stomach – Page 2 – Talk Bio

Actionable Insights Powered by AI

Zanidatamab Demonstrates Promising 30-Month Survival Rate in HER2-Positive Metastatic Gastroesophageal Adenocarcinoma

1 year ago talkbio0Tagged Antibodies, Bispecific, HER2-positive, Malignant neoplasm of stomach, Metastatic gastroesophageal adenocarcinoma, Neoplasms, Survival Rate, Zanidatamab

Zanidatamab, HER2-positive, metastatic gastroesophageal adenocarcinoma, bispecific antibody, survival rate, gastric cancer, oncology.

HUTCHMED Withdraws Fruquintinib Application for Second-Line Gastric Cancer Treatment in China

1 year ago talkbio0Tagged China, Fruquintinib, HUTCHMED, Malignant neoplasm of stomach, NDA, second-line

HUTCHMED, fruquintinib, gastric cancer, second-line treatment, China, NDA withdrawal